Brian P. Dunleavy has been covering health and medical research for more than 25 years, for United Press International and EverydayHealth.com, among other outlets. He is also the former editor of Infectious Disease Special Edition. In addition, he has written on other subjects for Biography.com, History.com, the Village Voice and amNewYork, among others. He holds a master’s degree from the University of Missouri School of Journalism.
New Drugs, Vaccines Continue to Advance in the Global Fight Against MERS-CoV: Public Health Watch
May 23rd 2018The virus associated with the Middle East may or may not pose a threat to the United States, but researchers here are still working hard to find treatments and preventative vaccines.
Read More
Understanding the New Enemy of Carbapenem-Resistant Acinetobacter Baumannii: Public Health Watch
March 21st 2018Investigators from the Centers for Disease Control and Prevention have determined the incidence of carbapenem-resistant Acinetobacter baumannii and "the basic epidemiology” of infections caused by these isolates in 8 metro areas.
Read More
WHO Calls Meeting to Discuss HIV Vaccine Strategies: Public Health Watch
March 14th 2018At present, multiple vaccine candidates are in various stages of research and development, including cabotegravir, which is currently in phase 3 trials, and vaccines based on broadly-neutralizing antibodies.
Read More
CDC Takes on Botulism in New CID Supplement
January 12th 2018In a special supplement to the January 15th issue of Clinical Infectious Diseases, researchers from various institutions across the country shared the latest findings on the diagnosis and management of botulism and highlighted the need for greater clinical understanding of its symptoms and related complications.
Read More
Updated Surviving Sepsis Campaign Guidelines Not Endorsed by IDSA
December 18th 2017The Infectious Diseases Society of America’s (IDSA) decision not to endorse the 2016 Surviving Sepsis Campaign Guidelines comes from disagreement on the diagnosis and management of the microbial etiology of the disease.
Read More
HHS Tick-Borne Disease Working Group Begins Efforts Despite Controversies: Public Health Watch
December 13th 2017The US Department of Health and Human Services Tick-Borne Disease Working Group held its first public meetings in Washington, DC, this week and it has already generated plenty of eye-grabbing headlines.
Read More